HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 76/4/639    most recent biolreprod.106.056960v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lei, Z.M. Articles by Rao, C.V. Search for Related Content PubMed PubMed Citation Articles by Lei, Z.M. Articles by Rao, C.V. Agricola Articles by Lei, Z.M. Articles by Rao, C.V.

Upregulation of Placental Indoleamine 2,3-Dioxygenase by Human Chorionic Gonadotropin

Division of Research,³ Department of Obstetrics, Gynecology and Women's Health, University of Louisville, Health Sciences Center, Louisville, Kentucky 40292 Laboratory of Radiation Safety,⁴ National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Aichi 474-8522 Japan

ABSTRACT

We tested the hypothesis that hCG can upregulate human trophoblast indoleamine 2, 3-dioxygenase (INDO), which catalyzes the breakdown of tryptophan in villous circulation. The results revealed that it can. Treatment of human trophoblasts with hCG resulted in a time and dose dependent increase in INDO mRNA and protein levels and its enzyme activity. The hCG effect was hormone specific and required the dimer conformation of hCG. The hCG effect required its receptors and was mediated by a cAMP dependent, but protein kinase A independent, mitogen-activated protein kinase 3/1 (MAPK3/1) signaling mechanism. In summary, the present data demonstrate a novel hCG effect on human placental INDO, which probably plays a key role at maternal fetal interface in preventing fetal rejection.

human chorionic gonadotropin, mechanisms of hormone action, placenta, pregnancy, trophoblast

²Current address: University of Texas at Houston, Houston, TX 77030.

Correspondence: ¹C.V. Rao, Division of Research, Department of Obstetrics, Gynecology and Women's Health, 438 MDR Building, 511 South Floyd St., University of Louisville Health Sciences Center, Louisville, KY 40292. FAX: 502 852 0881; e-mail: cvrao001{at}louisville.edu

This article has been cited by other articles:

				H. Wan, M. A. Versnel, L. M. E. Leijten, C. G. van Helden-Meeuwsen, D. Fekkes, P. J. M. Leenen, N. A. Khan, R. Benner, and R. C. M. Kiekens Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype J. Leukoc. Biol., April 1, 2008; 83(4): 894 - 901. [Abstract] [Full Text] [PDF]

				X.-L. Meng, O. M. Rennert, and W.-Y. Chan Human Chorionic Gonadotropin Induces Neuronal Differentiation of PC12 Cells through Activation of Stably Expressed Lutropin/Choriogonadotropin Receptor Endocrinology, December 1, 2007; 148(12): 5865 - 5873. [Abstract] [Full Text] [PDF]